Medstar Georgetown University Hospital, Division of Infectious Diseases and Travel Medicine, Washington, DC 20007, USA.
Infect Dis Clin North Am. 2013 Jun;27(2):429-57. doi: 10.1016/j.idc.2013.02.009.
More than a quarter of solid-organ transplant recipients are traveling to foreign regions where there are greater health risks than their home country. There may be higher risk of complications from typical travel-related illnesses and risk of opportunistic infections not faced by healthy travelers. Some vaccinations may be contraindicated after solid-organ transplant, and those that are safe may have decreased efficacy. Drug interactions between antirejection regimens and medications for malaria prophylaxis and traveler's diarrhea must be considered. This article discusses how providers can best advise and help protect these high-risk travelers.
超过四分之一的实体器官移植受者前往国外，这些地区的健康风险高于其原籍国。他们可能会因典型的旅行相关疾病而增加并发症的风险，并且可能会面临健康旅行者不会遇到的机会性感染。一些疫苗在实体器官移植后可能会被禁用，而那些安全的疫苗可能效果降低。抗排斥药物与疟疾预防药物和旅行者腹泻药物之间的药物相互作用必须加以考虑。本文讨论了提供者如何最好地提供建议并帮助保护这些高风险旅行者。
